Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" BCAN "BEHAB, CSPG7, MGC13038" ENSG00000132692 Brevican Q96GW7 1 156641390-156659532 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 144.2" "Group enriched" "Detected in some" 22 "Horizontal cells: 103.3;Melanocytes: 177.2" "Group enriched" "Detected in many" 77 "glioma: 348.5;melanoma: 75.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 8.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 8.2" "Cell line enhanced" "Detected in many" "HDLM-2: 24.7;K-562: 34.8;U-266/70: 20.9;U-266/84: 40.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007865, CAB025862" Enhanced Supported "Secreted in brain" NA NA 98000 "CAB025862: , HPA007865: AB_1078299" "unprognostic (7.14e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (4.80e-2)" "unprognostic (6.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-2)" "unprognostic (9.47e-3)" "unprognostic (2.76e-2)" "unprognostic (8.54e-2)" "unprognostic (5.40e-1)" "unprognostic (1.90e-1)" 1.4 5.8 51.8 1.6 35.9 1.3 1.4 10.4 144.2 2.3 2.4 30.5 1.3 4.6 2.7 9.5 1.6 2.4 3.1 1.5 40.8 22.9 1.4 1.3 1.5 1.5 26.6 21.5 1.4 1.3 1.3 0.7 1.7 15.1 1.4 1.3 4.3 2.0 2.4 1.6 9.0 5.0 2.4 13.0 1.6 2.4 2.0 26.7 0.0 1.4 0.0 1.3 2.3 0.3 0.6 0.0 8.2 0.4 0.0 0.0 0.0 14.0 9.7 0.0 2.6 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.3 6.9 0.0 15.0 0.0 0.3 9.9 0.1 0.0 0.0 24.7 0.9 2.4 6.4 8.0 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.3 0.0 1.3 34.8 6.9 0.0 4.0 0.0 0.0 0.7 7.5 1.4 0.0 16.1 0.0 0.0 1.7 0.0 0.2 0.0 0.0 14.6 0.8 0.0 0.9 3.0 0.0 8.0 2.9 3.8 20.9 40.2 0.0 2.9 6.5 1.1 8.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 35.9 10.4 33.3 40.8 22.9 26.6 21.5 15.1 26.7 0.0 0.0 0.0 0.0 6.2 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.4 103.3 1.7 0.0 0.0 4.3 0.3 0.0 177.2 0.0 0.0 1.9 0.4 0.0 0.0 0.0 2.3 0.0 1.9 5.4 6.4 1.5 0.0 0.0 0.0 0.0 BTBD17 "BTBD17A, LGALS3BPL, TANGO10A" ENSG00000204347 "BTB domain containing 17" A6NE02 17 74356416-74361946 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 18.2" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 9.5;testis cancer: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Group enriched" "Detected in some" 20 "AF22: 3.9;NTERA-2: 5.1;SCLC-21H: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025022 Approved "Secreted in brain" NA NA "HPA025022: AB_2067352" "unprognostic (2.63e-1)" "unprognostic (2.77e-1)" "unprognostic (4.82e-5)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (9.89e-3)" 0.4 1.5 5.4 0.4 5.1 0.4 0.4 5.6 18.2 0.4 0.4 2.7 0.0 1.2 0.4 0.4 0.4 0.4 0.4 0.4 3.7 5.7 0.4 0.4 0.4 0.4 3.8 1.8 0.4 0.4 0.4 0.2 0.4 6.1 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.5 0.4 3.7 0.6 1.4 0.5 2.2 0.0 0.6 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.1 5.6 8.2 3.7 5.7 3.8 1.8 6.1 2.2 0.0 0.0 0.0 0.0 0.0 0.8 2.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 CA10 "CA-RPX, CARPX, HUCEP-15" ENSG00000154975 "Carbonic anhydrase 10" Q9NS85 17 51630313-52160017 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 59.5;cervix, uterine: 23.4" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 230.7;Early spermatids: 106.6;Late spermatids: 56.3" "Cancer enhanced" "Detected in some" "glioma: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.2;RT4: 3.8;SCLC-21H: 11.7;SuSa: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054825, HPA057837" Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA054825: AB_2682617, HPA057837: AB_2683542" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" "unprognostic (3.43e-1)" "unprognostic (8.22e-2)" "unprognostic (4.43e-3)" "unprognostic (1.02e-3)" "unprognostic (1.01e-1)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (7.21e-3)" "unprognostic (9.18e-5)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" 0.5 3.8 14.4 0.5 6.3 0.5 0.5 59.5 36.7 23.4 0.8 1.7 0.0 0.8 0.7 0.5 0.6 0.7 0.6 0.5 8.0 12.4 7.8 0.5 0.5 0.5 7.0 5.0 2.5 0.8 0.5 1.8 14.2 18.3 0.5 0.7 2.9 1.5 0.5 0.5 0.5 1.1 0.6 4.2 0.5 0.6 6.0 1.3 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 2.2 3.8 11.7 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 6.3 59.5 17.9 8.0 12.4 7.0 5.0 18.3 1.3 0.0 0.0 0.0 0.0 0.0 230.7 0.3 0.0 0.0 0.0 3.5 3.9 0.0 13.3 0.0 106.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 56.3 1.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 9.7 0.0 0.0 0.9 1.0 0.0 0.1 0.0 0.0 0.0 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637942-48646312 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;hTERT-RPE1: 24.4;SCLC-21H: 16.7;U-266/84: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" NA NA "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favorable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favorable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favorable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 2.3 9.6 60.2 2.3 58.2 1.5 4.1 54.1 87.7 3.8 2.5 4.5 1.7 5.3 17.7 16.0 3.5 10.5 3.5 2.9 44.1 12.2 4.2 1.2 3.2 3.0 18.5 31.6 24.6 3.3 16.7 5.4 1.3 8.9 4.6 2.0 2.7 4.0 8.4 5.0 6.6 4.0 10.7 11.0 2.8 3.1 2.7 17.8 0.1 4.3 0.8 3.4 2.1 1.8 3.4 4.5 0.0 1.1 2.6 3.7 1.4 1.0 6.3 11.6 23.3 1.6 0.6 0.3 0.7 7.4 0.8 1.7 1.5 8.1 3.8 0.9 0.8 2.2 2.5 4.7 2.3 0.7 0.8 6.7 1.7 3.4 0.1 1.5 0.1 5.2 2.8 4.7 0.7 1.0 24.4 0.9 10.4 2.9 10.7 0.3 2.4 2.0 0.7 5.1 3.7 2.5 1.3 0.5 7.9 5.1 0.2 16.7 9.7 0.8 0.9 1.4 3.3 3.3 0.4 0.0 2.1 7.8 0.0 0.2 10.2 17.0 0.7 2.9 2.2 1.0 0.0 0.9 0.0 3.7 1.1 3.1 2.4 2.9 2.8 1.6 3.4 3.6 3.3 0.0 2.6 0.0 4.5 3.0 1.4 60.2 58.2 54.1 63.8 44.1 12.2 18.5 31.6 8.9 17.8 3.0 7.2 9.7 6.4 6.4 72.7 5.3 20.4 8.1 9.1 29.6 15.7 0.6 21.6 6.9 10.0 7.1 7.4 0.0 8.7 0.3 5.1 4.8 5.8 34.1 5.9 27.0 12.6 8.0 21.9 4.7 20.4 8.8 8.5 4.6 4.2 24.9 4.6 3.5 25.1 19.8 25.0 6.5 8.0 0.9 3.6 9.5 0.3 8.7 4.5 5.8 CBLN1 ENSG00000102924 "Cerebellin 1 precursor" P23435 16 49277917-49281831 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 106.6" "Group enriched" "Detected in some" 6 "Early spermatids: 80.9;Late spermatids: 214.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.5" "Region enriched" "Detected in many" 12 "cerebellum: 106.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "NTERA-2: 16.7;SCLC-21H: 53.2" "Region enriched" "Detected in many" 9 "cerebellum: 688.3" "Region enriched" "Detected in all" 15 "cerebellum: 300.1" "Secreted in brain" NA NA 2900000 "unprognostic (1.39e-2)" "unprognostic (1.88e-2)" "unprognostic (1.53e-1)" "unprognostic (3.16e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.65e-3)" "unprognostic (1.18e-2)" "unprognostic (6.31e-2)" "unprognostic (1.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.04e-2)" "unprognostic (7.68e-2)" "unprognostic (2.45e-1)" "unprognostic (1.06e-2)" "prognostic favorable (7.10e-4)" "unprognostic (1.60e-2)" 9.9 0.8 0.9 0.1 1.0 0.0 1.2 106.6 4.9 2.0 0.4 0.4 0.4 0.6 5.9 1.4 0.8 0.9 9.0 4.2 0.7 9.2 0.2 0.7 0.1 0.9 4.5 1.0 0.5 2.4 0.0 0.9 0.4 4.6 0.3 0.4 1.1 0.7 3.0 0.5 0.3 0.5 1.5 2.3 0.1 0.5 16.0 0.4 0.2 0.6 0.6 2.4 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 1.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.2 1.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 106.6 1.4 0.7 9.2 4.5 1.0 4.6 0.4 0.0 0.0 0.0 0.0 0.0 3.3 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 80.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.6 12.7 0.0 0.0 214.3 2.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.4 0.0 1.5 25.8 4.4 17.6 4.5 0.1 0.0 0.0 0.0 0.0 CBLN2 ENSG00000141668 "Cerebellin 2 precursor" Q8IUK8 18 72536680-72638521 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 33.8" "Cell type enriched" "Detected in some" 7 "Intestinal endocrine cells: 36.4" "Cancer enriched" "Detected in single" 7 "breast cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA 1300000 "unprognostic (2.03e-2)" "unprognostic (3.52e-1)" "unprognostic (1.13e-3)" "unprognostic (9.09e-5)" "unprognostic (7.10e-2)" "unprognostic (6.27e-3)" "unprognostic (7.39e-2)" "unprognostic (2.17e-1)" "unprognostic (1.37e-4)" "unprognostic (5.01e-4)" "unprognostic (8.15e-2)" "unprognostic (6.07e-4)" "unprognostic (7.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (4.93e-2)" 0.6 0.7 5.4 0.8 10.4 0.4 0.6 0.8 33.8 1.0 2.9 0.9 0.0 2.5 0.5 0.4 0.5 0.5 0.4 0.4 4.5 9.5 1.5 0.9 0.4 0.5 7.0 16.4 0.6 0.4 0.4 0.3 0.4 17.8 1.8 2.6 1.9 0.4 8.2 0.4 0.9 3.8 1.5 2.6 0.4 0.6 0.6 0.0 0.0 0.4 0.0 1.3 0.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.8 33.8 4.5 9.5 7.0 16.4 17.8 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 1.0 0.1 0.0 0.0 0.0 0.0 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell type enhanced" "Detected in some" 8 "Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 47 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" NA NA Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 5.0 10.9 0.3 4.2 8.6 1.7 2.2 0.5 2.0 1.8 0.9 2.6 1.9 0.3 0.6 2.3 1.1 12.7 0.4 0.0 3.5 0.8 2.8 0.3 0.7 18.9 1.0 2.1 1.7 7.0 1.5 0.8 0.5 14.2 2.1 0.6 0.0 0.5 0.1 1.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.6 0.3 0.6 0.4 6.6 6.1 1.2 2.5 0.2 9.9 2.3 2.0 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.5 0.0 1.0 0.5 2.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 3.6 0.2 0.8 0.8 0.0 1.4 0.5 0.3 0.0 1.2 0.0 0.1 0.5 0.7 0.0 0.4 0.5 CBLN4 "CBLNL1, dJ885A10.1" ENSG00000054803 "Cerebellin 4 precursor" Q9NTU7 20 55997440-56005472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.5;brain: 16.8;epididymis: 11.8" "Cell type enriched" "Detected in some" 4 "Peritubular cells: 35.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 49 "SH-SY5Y: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074497 Supported "Secreted in brain" NA NA 10000000 "HPA074497: " "unprognostic (3.61e-1)" "unprognostic (8.43e-3)" "unprognostic (2.43e-1)" "unprognostic (1.61e-2)" "unprognostic (1.99e-1)" "unprognostic (4.00e-1)" "unprognostic (3.25e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (3.88e-1)" "unprognostic (9.63e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-3)" "unprognostic (3.22e-4)" "unprognostic (7.50e-2)" "unprognostic (3.58e-2)" "unprognostic (1.79e-3)" 1.3 23.5 11.9 0.3 8.9 0.2 1.8 0.1 16.8 2.8 0.3 0.5 0.8 0.3 1.2 11.8 0.3 5.4 0.9 0.2 5.9 14.8 1.0 1.3 1.1 0.2 1.6 5.0 2.2 1.2 0.4 0.1 0.5 2.4 0.4 0.2 0.1 0.3 0.7 0.5 0.3 0.3 0.6 0.4 0.2 0.7 2.7 0.0 0.0 1.3 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 8.9 0.1 16.8 5.9 14.8 1.6 5.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.6 8.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 35.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CREG2 ENSG00000175874 "Cellular repressor of E1A stimulated genes 2" Q8IUH2 2 101345551-101387595 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 56.0" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 1.8;Early spermatids: 4.9;Late spermatids: 3.0;Pancreatic endocrine cells: 1.7;Spermatogonia: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "T-reg: 2.6" "Lineage enriched" "Detected in single" 5 "T-cells: 2.6" "Cell line enhanced" "Detected in some" "CACO-2: 3.6;HaCaT: 9.5;HeLa: 3.7;OE19: 10.4;PC-3: 3.8;RT4: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038224 Enhanced "Secreted in brain" NA NA "HPA038224: AB_10673167" "unprognostic (5.09e-2)" "unprognostic (3.78e-3)" "unprognostic (4.10e-3)" "unprognostic (8.15e-3)" "unprognostic (5.63e-3)" "unprognostic (9.68e-3)" "unprognostic (4.52e-8)" "unprognostic (3.86e-4)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (7.69e-2)" "unprognostic (5.41e-3)" "unprognostic (4.44e-2)" "unprognostic (2.91e-1)" "unprognostic (8.26e-3)" "unprognostic (7.77e-2)" 0.8 0.9 12.6 0.8 13.8 0.9 0.8 0.2 56.0 0.9 0.8 1.0 0.0 0.9 0.8 0.8 0.8 1.1 0.9 0.9 17.2 4.4 0.9 0.8 0.8 0.8 3.3 16.6 0.9 0.8 0.8 0.2 0.9 7.2 0.8 0.9 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.2 0.8 0.8 0.9 0.5 0.0 0.8 0.0 0.8 0.8 0.6 0.2 0.3 0.5 0.0 0.0 2.6 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.1 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 10.4 3.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.3 2.6 0.0 12.6 13.8 0.2 29.7 17.2 4.4 3.3 16.6 7.2 0.5 0.0 0.0 0.0 0.2 0.0 0.8 0.6 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.5 2.1 0.0 0.1 0.0 0.0 1.3 FAM19A1 "TAFA-1, TAFA1" ENSG00000183662 "Family with sequence similarity 19 member A1, C-C motif chemokine like" Q7Z5A9 3 68004216-68545625 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.9;brain: 28.0" "Cell type enriched" "Detected in some" 12 "Early spermatids: 14.9" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 13.9;MAIT T-cell: 10.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 7.5;naive CD4 T-cell: 8.2;naive CD8 T-cell: 11.5;T-reg: 5.0" "Lineage enriched" "Detected in many" 6 "T-cells: 13.9" "Cell line enriched" "Detected in single" 9 "REH: 6.1" "Low region specificity" "Detected in many" HPA013407 Approved "Secreted in brain" NA NA "HPA013407: AB_1848386" "unprognostic (5.19e-2)" "unprognostic (4.64e-3)" "unprognostic (1.97e-2)" "unprognostic (1.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.40e-2)" "unprognostic (3.42e-3)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-1)" "unprognostic (1.41e-2)" "unprognostic (7.87e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.99e-1)" "unprognostic (3.50e-4)" "unprognostic (5.77e-2)" 0.7 2.0 10.6 0.8 9.0 0.4 0.5 0.4 28.0 0.5 0.7 0.1 0.3 2.3 0.8 2.0 0.5 0.5 1.4 0.5 18.4 4.8 0.8 0.8 0.5 1.2 4.4 10.4 0.4 0.4 0.4 0.6 0.4 25.2 2.6 0.6 0.0 0.6 6.2 0.6 0.4 0.5 0.9 1.3 0.9 0.5 0.7 0.2 0.0 0.6 0.0 0.7 0.7 0.3 0.0 0.0 0.2 0.1 2.1 13.9 2.6 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 10.7 0.0 11.5 7.5 0.0 0.0 8.2 11.5 0.2 2.1 0.0 0.0 5.0 2.6 10.6 9.0 0.4 24.4 18.4 4.8 4.4 10.4 25.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 FAM19A4 TAFA-4 ENSG00000163377 "Family with sequence similarity 19 member A4, C-C motif chemokine like" Q96LR4 3 68731766-68953297 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.0;brain: 10.9" "Cell type enriched" "Detected in some" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.7;NTERA-2: 13.9;SuSa: 4.1" "Region enriched" "Detected in some" 5 "thalamus: 14.7" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (1.92e-1)" "unprognostic (9.97e-3)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (8.78e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-2)" "unprognostic (1.22e-1)" "unprognostic (3.66e-2)" "unprognostic (8.06e-2)" "unprognostic (2.50e-1)" 0.5 26.0 2.3 0.9 7.3 0.5 0.6 0.4 7.5 0.5 0.7 10.8 0.0 0.6 0.5 0.5 1.1 0.6 2.7 0.5 2.9 4.2 0.7 0.5 0.6 0.6 10.9 1.8 1.0 0.5 0.5 1.8 1.8 8.7 2.2 0.6 5.0 0.7 1.1 0.5 0.5 0.5 1.0 10.4 0.6 8.3 2.1 8.2 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.3 0.4 7.5 2.9 4.2 10.9 1.8 8.7 8.2 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 FSTL5 "DKFZp566D234, KIAA1263" ENSG00000168843 "Follistatin like 5" Q8N475 4 161383897-162164035 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 106.9" "Group enriched" "Detected in some" 10 "Bipolar cells: 248.5;Cone photoreceptor cells: 435.9;Rod photoreceptor cells: 131.6" "Cancer enriched" "Detected in single" 6 "melanoma: 1.7" "Region enriched" "Detected in all" 6 "cerebellum: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (4.90e-2)" "unprognostic (4.46e-1)" "unprognostic (1.52e-2)" "unprognostic (2.03e-1)" "unprognostic (3.66e-2)" "unprognostic (2.99e-2)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.61e-1)" "unprognostic (1.08e-10)" "unprognostic (8.45e-4)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (6.60e-3)" 0.5 12.1 3.5 0.6 6.9 0.5 0.5 106.9 19.9 0.5 0.6 0.6 0.0 0.5 0.5 1.7 0.5 0.6 0.5 0.5 3.2 5.9 0.6 0.5 0.5 0.5 3.0 3.0 0.5 1.0 0.5 1.1 0.7 18.2 0.5 0.8 7.1 0.5 0.6 0.5 0.8 0.6 0.6 3.1 0.5 0.5 1.5 2.9 0.0 0.6 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 5.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 8.8 0.0 3.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.9 106.9 6.9 3.2 5.9 3.0 3.0 18.2 2.9 0.0 0.0 0.0 0.0 0.2 248.5 0.1 0.0 0.0 0.0 0.0 435.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 27.0 0.0 0.0 0.0 1.7 0.6 0.0 1.7 0.0 0.0 18.6 0.1 0.0 0.4 0.0 131.6 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 HAPLN2 BRAL1 ENSG00000132702 "Hyaluronan and proteoglycan link protein 2" Q9GZV7 1 156619294-156625725 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 39 "brain: 108.1" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 32.3" "Cancer enriched" "Detected in some" 10 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.1;U-266/70: 4.6;U-87 MG: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045765 Enhanced "Secreted in brain" NA NA "HPA045765: AB_10964781" "unprognostic (3.19e-3)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-1)" "unprognostic (2.44e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-3)" "unprognostic (1.31e-1)" "unprognostic (8.25e-2)" "unprognostic (5.54e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-2)" "unprognostic (1.08e-1)" "unprognostic (2.25e-1)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 1.5 1.5 11.0 1.3 21.1 1.3 1.3 4.4 45.3 1.3 1.3 43.6 0.0 2.7 1.6 1.3 1.3 1.4 1.3 1.3 21.2 13.9 1.4 1.3 1.4 1.3 49.3 9.3 1.3 1.3 1.6 0.0 1.3 43.1 1.9 1.3 0.0 1.4 1.5 1.9 1.6 1.7 1.3 108.1 1.3 1.3 1.7 31.5 0.0 1.3 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 4.6 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 21.1 4.4 15.1 21.2 13.9 49.3 9.3 43.1 31.5 0.0 0.0 0.0 0.0 0.1 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 32.3 7.6 0.7 1.9 0.0 0.0 0.0 0.0 0.1 HAPLN4 "BRAL2, KIAA1926" ENSG00000187664 "Hyaluronan and proteoglycan link protein 4" Q86UW8 19 19255641-19262796 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 38.5;intestine: 24.3" "Cell type enriched" "Detected in single" 6 "Hepatocytes: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 5.7;NTERA-2: 14.9;SCLC-21H: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055856 Enhanced "Secreted in brain" NA NA "HPA055856: AB_2682946" "unprognostic (3.36e-4)" 0.5 1.9 3.0 0.4 7.5 0.4 0.7 8.9 38.5 2.4 0.6 1.6 0.0 19.6 1.6 0.5 0.4 0.7 0.6 0.5 8.9 9.4 0.5 7.5 0.6 0.4 7.8 2.7 1.4 1.3 0.4 0.2 0.7 26.4 1.1 0.6 0.4 0.5 0.8 0.4 0.4 24.3 0.6 3.8 0.4 0.8 0.5 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 5.7 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.5 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 7.5 8.9 38.5 8.9 9.4 7.8 2.7 26.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 IGLON5 LOC402665 ENSG00000142549 "IgLON family member 5" A6NGN9 19 51311848-51330354 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 33.6;testis: 11.5" "Group enriched" "Detected in some" 15 "Bipolar cells: 30.6;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "testis cancer: 12.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 25.2;NTERA-2: 11.4;SH-SY5Y: 16.4;SuSa: 7.4;U-2 OS: 4.8" "Low region specificity" "Detected in all" HPA041994 Approved "Secreted in brain" NA NA "HPA041994: AB_10794641" "unprognostic (2.09e-1)" "unprognostic (5.76e-2)" "unprognostic (1.80e-2)" "unprognostic (8.87e-3)" "unprognostic (2.33e-1)" "unprognostic (2.66e-1)" "unprognostic (3.47e-4)" "unprognostic (6.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.89e-3)" "unprognostic (1.59e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.62e-7)" "unprognostic (1.77e-2)" "unprognostic (9.28e-2)" "unprognostic (1.36e-2)" "unprognostic (1.86e-3)" 2.0 4.6 9.6 1.1 6.0 1.9 0.7 33.6 16.5 0.6 0.8 0.8 0.0 0.9 0.8 2.2 2.8 0.7 1.0 1.2 9.5 13.7 0.6 2.3 0.6 0.6 11.1 8.4 1.5 1.1 0.5 0.5 1.3 29.3 1.1 0.7 3.0 1.1 2.4 0.6 1.5 1.1 0.8 10.9 0.7 0.7 11.5 2.6 0.0 0.6 0.0 0.6 1.1 0.4 0.0 0.9 1.4 0.3 0.2 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 2.4 0.0 0.1 0.1 16.4 0.0 0.0 0.0 7.4 0.1 1.5 0.0 0.0 4.8 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.9 0.0 0.0 9.6 6.0 33.6 10.7 9.5 13.7 11.1 8.4 29.3 2.6 0.0 0.0 0.0 0.0 0.0 30.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 74.7 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 0.0 LGI1 "EPITEMPIN, EPT, ETL1, IB1099" ENSG00000108231 "Leucine rich glioma inactivated 1" O95970 10 93757809-93806272 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 45.1" "Group enriched" "Detected in some" 4 "Early spermatids: 5.9;Hepatocytes: 5.9" "Group enriched" "Detected in some" 7 "glioma: 1.8;testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.3;CACO-2: 2.4;NTERA-2: 8.9;SuSa: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (1.26e-1)" "unprognostic (4.68e-2)" "unprognostic (2.45e-2)" "unprognostic (1.01e-1)" "unprognostic (8.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.24e-3)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" "unprognostic (8.71e-2)" "unprognostic (2.21e-1)" "unprognostic (5.93e-2)" "unprognostic (4.65e-1)" 1.4 4.5 15.3 1.4 30.6 1.1 1.5 18.1 45.1 1.4 4.4 7.3 0.0 1.3 1.3 1.2 7.2 1.2 2.6 1.5 16.3 10.1 1.2 5.4 1.2 1.2 9.6 17.3 1.3 1.5 1.1 6.5 1.1 35.6 2.2 5.2 10.9 1.1 1.9 9.2 1.2 2.3 2.1 7.3 1.1 2.4 1.5 10.4 0.0 1.2 0.0 1.3 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 30.6 18.1 20.7 16.3 10.1 9.6 17.3 35.6 10.4 0.0 0.0 0.0 0.2 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 5.9 0.0 0.0 0.0 0.6 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 LGI4 ENSG00000153902 "Leucine rich repeat LGI family member 4" Q8N135 19 35124513-35142451 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.3;skeletal muscle: 59.4" "Group enriched" "Detected in many" 7 "Muller glia cells: 88.9;Sertoli cells: 77.6;Smooth muscle cells: 120.2" "Group enriched" "Detected in many" 6 "glioma: 4.5;melanoma: 11.5;renal cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.2" "Cell line enriched" "Detected in single" 30 "WM-115: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042116, HPA043556" Approved Approved "Golgi apparatus" "Secreted in brain" NA NA "Golgi apparatus" "HPA042116: AB_2677855, HPA043556: AB_2678550" "unprognostic (3.79e-1)" "unprognostic (6.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-2)" "unprognostic (3.71e-2)" "unprognostic (2.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.71e-2)" "unprognostic (4.47e-1)" "unprognostic (7.73e-2)" "unprognostic (7.13e-2)" 35.6 10.7 31.7 7.9 18.5 2.0 9.9 16.3 36.5 22.3 26.9 17.1 6.3 7.4 13.2 8.9 9.0 12.2 9.4 12.2 23.3 7.9 3.4 4.7 5.3 4.5 15.4 31.5 5.8 4.5 4.4 1.0 7.6 26.0 10.4 8.1 8.7 8.7 24.7 59.4 5.9 11.7 9.6 50.3 3.5 8.5 3.1 15.1 0.0 5.6 4.8 2.4 9.6 24.4 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 26.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 31.7 18.5 16.3 36.5 23.3 7.9 15.4 31.5 26.0 15.1 0.0 0.0 0.0 0.4 2.3 0.8 10.4 0.0 1.4 1.2 1.8 2.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.2 8.0 0.6 0.0 1.7 0.1 0.0 1.7 12.9 0.0 0.0 13.6 1.1 10.1 0.0 0.1 88.9 0.1 2.5 6.7 0.0 2.8 77.6 120.2 0.6 0.9 2.0 0.0 0.0 0.2 0.7 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "Early spermatids: 18.8;Paneth cells: 21.8" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 0.0 0.0 0.0 0.1 0.6 2.3 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.6 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 1.8 0.2 0.1 21.8 0.0 0.6 0.6 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.9 0.7 NPTX1 ENSG00000171246 "Neuronal pentraxin 1" Q15818 17 80467148-80477843 "Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.9" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 164.9" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.5" "Cell line enhanced" "Detected in some" "HAP1: 12.4;HeLa: 9.7;SiHa: 15.8;U-138 MG: 33.8;WM-115: 46.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6" HPA077062 Enhanced Approved "Secreted in brain" NA NA 1000000 "HPA077062: AB_2732329" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-2)" "unprognostic (6.95e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.63e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "unprognostic (9.63e-3)" "unprognostic (1.05e-6)" "unprognostic (1.41e-4)" "unprognostic (1.35e-1)" "unprognostic (8.86e-6)" "unprognostic (2.71e-3)" 1.0 3.4 28.8 1.4 14.7 0.8 1.1 68.9 62.5 0.8 9.1 0.2 0.0 1.3 1.3 2.5 1.4 1.4 1.7 0.7 15.5 3.0 0.8 0.7 1.0 1.4 1.0 18.2 0.7 0.7 0.7 0.8 1.6 4.6 1.3 2.5 0.6 0.7 2.9 1.0 3.2 1.5 1.4 1.9 2.3 1.5 1.3 0.0 0.9 0.7 0.0 0.7 0.9 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.7 0.2 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 1.3 0.0 12.4 0.0 0.0 0.0 7.7 0.0 9.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.2 0.0 0.0 8.4 0.0 15.8 0.0 0.0 0.1 0.0 0.2 0.1 33.8 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 28.8 14.7 68.9 29.9 15.5 3.0 1.0 18.2 4.6 0.0 0.0 0.0 0.0 0.1 1.3 8.7 2.8 0.0 0.0 1.2 0.0 164.9 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.9 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.1 0.0 2.6 0.0 0.9 1.1 0.5 2.6 0.1 0.0 0.0 0.0 NTN3 NTN2L ENSG00000162068 "Netrin 3" O00634 16 2471499-2474145 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 8.2;SCLC-21H: 10.5;SH-SY5Y: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050817 Uncertain "Secreted in brain" NA NA "HPA050817: AB_2681247" "unprognostic (2.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.79e-1)" "unprognostic (9.17e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-2)" "unprognostic (9.62e-3)" "unprognostic (2.11e-1)" "unprognostic (4.55e-2)" "unprognostic (6.95e-2)" "unprognostic (5.58e-2)" "unprognostic (2.34e-1)" "unprognostic (1.35e-2)" "unprognostic (3.26e-2)" "unprognostic (6.68e-2)" "unprognostic (2.39e-2)" "unprognostic (6.61e-2)" 1.2 0.7 5.8 0.5 6.0 0.8 0.5 1.4 3.8 1.8 0.6 1.6 0.0 0.3 1.9 0.5 0.4 0.8 0.6 0.8 6.3 2.4 0.6 1.5 0.5 0.7 1.8 3.0 0.3 2.1 0.3 1.3 0.5 4.7 0.6 0.3 1.3 1.0 0.9 1.0 0.3 0.9 0.3 2.3 1.1 0.5 3.1 3.3 2.5 0.8 0.0 0.4 0.4 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.2 0.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 1.3 1.2 0.1 2.4 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 1.2 0.3 0.0 0.1 8.2 0.1 0.2 0.0 0.0 10.5 5.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.5 0.1 0.1 0.6 0.4 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 6.0 1.4 3.8 6.3 2.4 1.8 3.0 4.7 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXPH1 ENSG00000122584 "Neurexophilin 1" P58417 7 8433955-8752963 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "adrenal gland: 41.1;brain: 30.1" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.1;Early spermatids: 4.3;Late spermatids: 1.3;Rod photoreceptor cells: 3.4" "Group enriched" "Detected in some" 62 "breast cancer: 2.3;glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 15.4;WM-115: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-2)" "unprognostic (1.46e-4)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (5.32e-1)" "unprognostic (9.46e-2)" 0.8 41.1 9.6 0.7 9.8 0.7 1.1 3.6 30.1 0.7 0.7 3.0 0.0 0.7 0.7 0.7 0.7 0.7 0.8 0.7 6.5 13.9 0.7 0.7 0.7 0.7 6.2 7.1 0.7 0.7 0.7 1.9 0.7 6.8 0.7 0.7 0.0 1.0 0.7 0.7 0.7 0.7 0.7 3.3 0.7 0.7 0.9 1.9 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.4 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 9.8 3.6 11.5 6.5 13.9 6.2 7.1 6.8 1.9 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 NXPH2 NPH2 ENSG00000144227 "Neurexophilin 2" O95156 2 138670772-138780348 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "brain: 23.0;kidney: 8.0;ovary: 19.3" "Cell type enriched" "Detected in single" 7 "Distal tubular cells: 1.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 4 "pons and medulla: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034759 Approved "Secreted in brain" NA Yes "HPA034759: AB_10669732" "unprognostic (5.83e-2)" "unprognostic (8.83e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.80e-1)" 0.4 0.5 3.1 0.6 3.7 0.2 0.4 0.8 6.0 0.6 0.3 0.0 0.0 0.2 1.1 0.5 0.2 0.6 0.2 0.2 1.9 1.5 8.0 0.3 0.3 0.2 2.4 2.0 19.3 0.2 0.4 0.4 0.4 23.0 0.3 0.3 0.5 0.2 1.1 0.2 0.2 0.4 0.3 0.7 0.2 0.2 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 2.4 1.6 6.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 10.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.7 0.8 5.6 1.9 1.5 2.4 2.0 23.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXPH3 NPH3 ENSG00000182575 "Neurexophilin 3" O95157 17 49575858-49583827 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "monocytes: 7.2;Muller glia cells: 8.9;Peritubular cells: 13.4;Smooth muscle cells: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 18.1;BJ: 5.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 61.3" HPA073819 Approved "Vesicles,Mitotic spindle" "Secreted in brain" NA NA Vesicles "Mitotic spindle" "HPA073819: " "unprognostic (2.39e-2)" "unprognostic (4.75e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-1)" "unprognostic (1.92e-1)" "unprognostic (3.30e-1)" "unprognostic (1.97e-1)" "unprognostic (8.01e-2)" "unprognostic (4.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-2)" "unprognostic (6.33e-2)" "unprognostic (4.62e-4)" "unprognostic (2.59e-2)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (5.05e-3)" 4.5 2.4 3.2 2.9 7.4 0.3 3.9 23.5 16.4 18.9 8.9 3.4 0.0 1.2 11.3 3.8 4.5 8.0 4.0 5.0 4.7 3.4 0.8 0.4 5.1 1.3 2.7 7.7 9.2 1.6 0.7 7.2 4.1 5.1 11.2 1.6 6.8 6.0 12.3 2.6 2.1 1.7 11.0 1.7 1.2 3.6 3.5 3.2 0.0 1.4 3.9 1.2 15.9 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 18.1 5.7 0.6 0.4 0.2 0.9 0.0 0.0 0.3 0.1 1.2 0.1 0.6 0.2 0.1 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.2 0.1 0.5 0.0 0.0 2.0 0.1 0.0 0.0 0.4 0.3 0.1 0.0 1.9 0.1 0.0 0.0 0.0 0.7 1.8 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 7.4 23.5 11.4 4.7 3.4 2.7 7.7 5.1 3.2 0.0 2.2 0.0 0.2 0.3 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.9 2.5 0.3 0.0 0.0 0.2 0.0 0.0 1.8 0.3 0.0 4.0 0.0 1.7 7.2 0.0 8.9 0.0 0.0 13.4 0.0 1.1 0.0 12.5 0.1 0.6 1.0 0.1 0.0 0.0 0.1 NXPH4 NPH4 ENSG00000182379 "Neurexophilin 4" O95158 12 57216795-57226449 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1;skin 1: 17.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 12.9;Cytotrophoblasts: 24.5;Muller glia cells: 15.7;Syncytiotrophoblasts: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 35.1;RH-30: 28.7;RPMI-8226: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "unprognostic (1.08e-2)" "unprognostic (4.84e-2)" "unprognostic (2.70e-3)" "prognostic unfavorable (6.21e-4)" "prognostic unfavorable (5.42e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (3.07e-1)" "unprognostic (1.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (7.83e-2)" "unprognostic (2.73e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-3)" 2.8 1.4 2.6 0.8 3.8 0.9 1.9 18.1 9.4 1.9 0.4 0.0 0.0 0.3 0.3 0.7 2.5 0.4 0.4 4.6 1.6 3.7 0.7 1.1 0.4 1.1 2.6 6.2 0.3 1.6 0.7 0.7 4.8 10.9 8.2 0.3 2.7 3.2 0.4 0.6 17.7 0.4 0.5 3.4 0.8 0.4 1.3 0.0 0.0 1.0 0.7 1.7 0.5 2.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.6 0.1 35.1 4.0 1.0 3.2 2.2 5.2 1.0 1.2 2.2 0.4 8.6 3.5 2.3 1.5 7.3 4.7 1.0 0.3 1.5 9.4 0.0 0.3 0.1 3.5 0.3 1.1 0.9 1.8 0.9 1.5 1.1 0.0 0.5 0.3 9.1 0.7 8.2 0.0 0.0 0.3 0.1 6.1 0.4 28.7 18.8 0.0 1.4 5.7 0.3 5.0 10.3 10.0 0.1 10.2 0.2 0.0 2.5 8.4 1.0 2.5 5.0 1.0 3.0 1.6 4.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.8 18.1 5.7 1.6 3.7 2.6 6.2 10.9 0.0 0.0 0.0 1.3 0.2 12.9 2.7 0.6 0.0 0.0 0.0 0.0 7.9 24.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 1.6 0.2 2.9 0.0 0.0 1.7 1.6 6.9 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 15.7 0.9 0.0 0.4 0.0 0.3 0.0 2.0 0.0 4.9 9.2 24.5 0.0 0.0 0.3 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802574-101997030 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 25.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.7 3.2 5.0 1.4 13.7 0.7 0.8 24.2 30.0 0.9 1.8 0.4 0.0 1.0 0.9 1.2 0.7 0.8 0.8 0.7 4.8 7.4 1.5 0.8 0.7 0.7 6.0 11.9 0.8 0.7 0.7 2.4 0.8 16.6 0.7 1.7 0.3 0.8 0.7 0.7 0.7 2.1 1.3 1.5 0.9 1.0 0.9 0.7 0.0 1.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.7 24.2 26.7 4.8 7.4 6.0 11.9 16.6 0.7 0.0 0.0 0.0 0.0 0.0 25.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681353-51721031 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 118.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 115.1;Cone photoreceptor cells: 96.2;Horizontal cells: 139.8;Intestinal endocrine cells: 142.5;Rod photoreceptor cells: 63.1" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NTERA-2: 20.4;SCLC-21H: 48.9;SH-SY5Y: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" NA NA 4800000 Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239" "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 1.7 12.9 29.6 2.1 25.4 1.7 1.7 33.4 118.3 1.5 2.4 6.5 0.0 2.9 1.5 1.6 1.6 1.6 1.6 1.5 22.6 23.5 1.5 1.5 1.8 1.7 13.6 37.7 1.5 11.5 1.4 23.7 1.5 27.1 1.6 2.8 1.3 1.5 1.4 1.5 1.8 2.6 1.7 13.2 1.5 8.7 2.9 7.3 0.0 2.1 0.0 1.5 1.6 0.1 0.9 1.2 1.9 0.5 0.3 0.8 0.2 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 20.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 48.9 23.1 0.1 0.1 0.0 6.6 0.0 1.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.1 4.3 0.4 0.4 0.6 0.8 0.2 0.5 0.9 0.6 0.4 0.4 0.7 0.5 0.6 1.9 0.3 0.5 1.2 0.2 0.2 29.6 25.4 33.4 40.6 22.6 23.5 13.6 37.7 27.1 7.3 0.0 0.0 0.0 0.0 0.2 115.1 0.2 0.0 0.0 0.0 0.0 96.2 0.0 1.7 0.4 13.3 0.6 0.0 0.0 0.9 0.0 0.2 0.5 0.0 0.0 0.4 139.8 142.5 1.8 0.0 9.2 0.0 0.0 1.7 11.8 0.2 11.7 8.7 0.0 0.4 0.0 63.1 0.0 0.1 15.8 4.9 0.0 0.0 0.0 0.2 0.0 SCRG1 SCRG-1 ENSG00000164106 "Stimulator of chondrogenesis 1" O75711 4 173384701-173406380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.4" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 148.4" "Cancer enriched" "Detected in many" 6 "glioma: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 13 "HSkMC: 6.8;WM-115: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012882 Approved "Secreted in brain" NA NA "HPA012882: AB_1856635" "unprognostic (1.09e-1)" "unprognostic (1.83e-2)" "unprognostic (2.60e-5)" "unprognostic (2.58e-1)" "unprognostic (3.22e-2)" "unprognostic (7.51e-2)" "unprognostic (3.58e-2)" "unprognostic (1.14e-3)" "unprognostic (2.08e-1)" "unprognostic (2.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (3.95e-10)" "unprognostic (4.86e-2)" "unprognostic (2.21e-1)" "unprognostic (4.34e-3)" "unprognostic (8.74e-4)" 5.8 3.1 19.2 2.6 18.6 2.2 2.3 6.0 30.6 2.1 2.9 15.9 4.0 2.5 2.5 7.7 2.3 2.1 5.1 3.6 19.9 12.0 1.5 1.4 1.5 1.5 24.9 12.9 1.6 1.8 1.2 1.1 1.6 20.5 6.4 2.7 0.0 3.4 11.6 1.9 2.0 2.0 15.6 33.4 2.4 2.8 16.3 22.5 0.0 1.5 0.3 1.3 4.1 1.0 1.4 1.3 4.4 1.8 1.6 1.0 0.4 0.1 0.0 0.9 0.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.8 0.2 0.2 6.8 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.1 19.8 3.9 1.8 1.2 0.8 1.2 0.6 0.8 0.6 0.7 0.7 1.4 0.8 1.0 4.4 1.6 1.3 1.3 0.5 0.4 19.2 18.6 6.0 16.7 19.9 12.0 24.9 12.9 20.5 22.5 0.0 4.0 0.5 1.0 3.2 11.8 0.8 0.0 1.4 1.2 0.0 35.3 0.2 0.0 0.2 14.9 2.0 0.0 0.0 0.0 0.2 5.2 1.4 9.2 0.0 0.5 15.9 1.2 6.2 3.1 21.8 24.2 1.6 21.9 0.0 0.0 148.4 0.1 0.0 19.4 0.0 30.2 12.9 10.9 1.9 2.2 2.3 0.6 3.9 0.2 0.7 SLITRK1 "KIAA1910, LRRC12" ENSG00000178235 "SLIT and NTRK like family member 1" Q96PX8 13 83877205-83882393 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 30.6" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 6.6" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 7.6;AF22: 3.2;LHCN-M2: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074835 Enhanced "Secreted in brain" NA NA 270000 "HPA074835: " "unprognostic (2.29e-1)" "unprognostic (4.32e-1)" "unprognostic (4.71e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (7.95e-2)" 0.9 1.3 16.7 0.9 9.5 0.9 1.0 2.0 30.6 1.2 1.0 6.3 0.0 1.0 1.0 1.0 0.9 0.9 1.0 0.9 16.9 7.3 1.0 0.9 0.9 0.9 7.3 14.9 0.9 3.1 0.9 3.1 0.9 5.8 0.9 1.0 0.1 1.0 1.4 1.0 0.9 0.9 0.9 3.7 0.9 1.0 1.0 8.5 0.0 0.9 0.0 0.9 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 3.2 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 9.5 2.0 21.5 16.9 7.3 7.3 14.9 5.8 8.5 0.0 0.0 0.0 0.0 0.0 6.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSPO "FLJ36112, KIAA0543, SCO-spondin" ENSG00000197558 SCO-spondin 7 149776042-149833979 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7;salivary gland: 1.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 24.9;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9;Muller glia cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;hTERT-RPE1: 1.4;RPMI-8226: 2.7" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 13 "midbrain: 44.5" "Secreted in brain" NA NA "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.95e-4)" "unprognostic (5.81e-3)" "unprognostic (3.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.41e-3)" "unprognostic (9.17e-2)" "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.59e-5)" "unprognostic (1.04e-1)" "unprognostic (2.65e-10)" "unprognostic (1.19e-1)" "unprognostic (2.94e-1)" "unprognostic (8.15e-3)" "unprognostic (2.46e-2)" 0.6 0.0 0.3 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 1.7 0.1 0.1 0.3 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.7 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.5 0.7 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 2.7 0.1 0.0 0.4 0.5 0.0 0.1 0.0 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.9 3.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 15.9 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 TMEM155 FLJ30834 ENSG00000164112 "Transmembrane protein 155" Q4W5P6 4 121758933-121765427 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.6" "Cell type enriched" "Detected in some" 4 "Cytotrophoblasts: 15.1" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebral cortex: 25.6" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.3;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 7.4;HAP1: 3.4;LHCN-M2: 10.5;MOLT-4: 6.3" HPA077585 Approved "Secreted in brain" NA NA "HPA077585: AB_2732353" "unprognostic (9.67e-3)" "unprognostic (3.25e-3)" "unprognostic (3.13e-2)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (5.73e-3)" "unprognostic (3.63e-2)" "unprognostic (1.49e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-3)" "unprognostic (4.40e-3)" "unprognostic (1.38e-1)" "unprognostic (3.82e-7)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.02e-2)" "unprognostic (2.04e-1)" 0.6 0.3 5.9 0.5 8.3 0.3 0.3 0.3 25.6 0.4 1.3 0.0 0.0 0.4 0.3 0.3 0.5 0.3 0.4 0.4 7.9 1.6 0.3 0.3 0.6 4.0 0.9 8.9 0.3 0.3 0.2 0.2 6.1 0.7 0.5 0.7 0.9 0.5 0.6 0.3 0.3 0.6 0.9 0.3 0.8 0.5 0.7 0.0 0.0 0.3 0.0 0.6 0.5 0.3 0.0 0.0 0.7 0.0 0.0 2.3 0.3 0.0 0.0 0.1 0.0 1.4 0.3 1.0 0.7 0.2 0.3 0.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 3.4 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 10.5 0.0 6.3 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.3 5.9 8.3 0.3 25.6 7.9 1.6 0.9 8.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 3.8 0.0 0.0 0.0 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell type enhanced" "Detected in some" 26 "Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Secreted in brain" NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 25.1 1.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 0.0 0.0 0.0 0.0 0.0 37.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 17.5 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.7 0.0 7.3 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.2 0.1